Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...
Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and StudiesAUSTIN, Texas, Jan.
Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.
Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Vector Security has provided intelligent security solutions for more than 50 years. Headquartered in Pittsburgh, the company offers a full suite of electronic security services for residential, ...
Background A few small studies have reported on the mechanisms of ACL injury in professional male football. Aim To describe the mechanisms, situational patterns and biomechanics (kinematics) of ACL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback